DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depakote (Divalproex Sodium) - Published Studies

 
 



Depakote Related Published Studies

Well-designed clinical trials related to Depakote (Divalproex)

Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence. [2012]

Chronic divalproex sodium use and brain atrophy in Alzheimer disease. [2011.09.27]

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. [2011.08]

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes. [2011.07.30]

Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial. [2011.06]

Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. [2011.02]

Fasted state bioavailability of two delayed release formulations of divalproex sodium in healthy Iranian volunteers. [2011]

Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder. [2011]

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. [2011]

Symptomatic response to divalproex in subtypes of conduct disorder. [2011]

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes. [2011]

A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. [2010.10]

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. [2010.09]

Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. [2010.08]

Divalproex extended-release in acute bipolar II depression. [2010.07]

Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania. [2010.05]

A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania. [2010.04]

Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. [2010.03]

A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. [2010]

A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania. [2010]

Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. [2010]

Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. [2010]

Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. [2009.12]

Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. [2009.11]

Overnight versus progressive conversion of multiple daily-dose divalproex to once-daily divalproex extended release: which strategy is better tolerated by adults with intellectual disabilities? [2009.10]

Olanzapine-Divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. [2009.09.22]

A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. [2009.05]

A preliminary controlled trial of divalproex in posttraumatic stress disorder. [2009.04]

Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. [2009.04]

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). [2009.04]

Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. [2009.04]

A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. [2009.01]

Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. [2009.01]

Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder. [2009]

Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. [2008.11]

Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. [2008.02]

Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study. [2007.12]

Divalproex Sodium for the Treatment of PTSD and Conduct Disordered Youth: A Pilot Randomized Controlled Clinical Trial. [2007.10]

A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. [2007.07]

Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. [2007.05]

Efficacy profiles of psychopharmacology: divalproex sodium in conduct disorder. [2006.09]

Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. [2006.08]

Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications. [2006.04]

Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. [2006.04]

A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. [2006.03]

Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrations. [2006.03]

A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease. [2005.12]

Baseline predictors of response to divalproex in conduct disorder. [2005.12]

A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. [2005.11]

Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. [2005.11]

Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo. [2005.10]

Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis. [2005.09]

Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC). [2005.09]

Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial. [2005.06]

Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. [2005.06]

Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. [2005.05]

Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial. [2005.04]

Divalproex in the treatment of bipolar depression: a placebo-controlled study. [2005.04]

Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. [2005.03]

Extended-release divalproex in child and adolescent outpatients with epilepsy. [2005.03]

Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions. [2005.02]

Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. [2005.01]

Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. [2005.01]

Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study. [2005.01]

Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. [2004.12]

Pharmacokinetics and safety of extended-release divalproex sodium tablets: morning versus evening administration. [2004.11.01]

Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers. [2004.11]

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. [2004.06]

Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone. [2004.03]

Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. [2004.01]

Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder. [2004]

Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial. [2003.10]

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. [2003.07]

Maintenance efficacy of divalproex in the prevention of bipolar depression. [2003.07]

Once-a-day controlled-release dosage form of divalproex sodium I: formulation design and in vitro/in vivo investigations. [2003.06]

Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. [2003.06]

Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. [2003.03]

Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. [2003.01]

A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. [2002.12]

The use of divalproex in alcohol relapse prevention: a pilot study. [2002.08.01]

Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures. [2002.08]

A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. [2002.06.11]

Olanzapine versus divalproex in the treatment of acute mania. [2002.06]

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. [2002.05]

Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. [2002.04]

Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers. [2002.03]

Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. [2002]

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression. [2001.12]

Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. [2001.09]

[Prediction of treatment response in acute mania: controlled clinical trials with divalproex] [2001.05]

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. [2001.03]

Placebo-controlled study of divalproex sodium for agitation in dementia. [2001.01]

Effects of divalproex versus lithium on length of hospital stay among patients with bipolar disorder. [2000.09]

Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. [2000.06]

Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. [2000.06]

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. [2000.05]

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. [2000.05]

Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. [1999.12]

Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. [1999.08]

A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. [1997.09]

Divalproex sodium in migraine prophylaxis: a dose-controlled study. [1997.04]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014